Regional variations in action potential alternans in isolated murine Scn5a+/- hearts during dynamic pacing

Acta Physiologica

Volumn 200, Issue 2, 2010, Pages 129-146

  Matthews, G D K ^a   Martin, C A ^a   Grace, A A ^a   Zhang, Y ^a,b   Huang, C L H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

alternans; arrhythmogenesis; Na+ channel; Scn5a+

Indexed keywords

FLECAINIDE; QUINIDINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BRUGADA SYNDROME; CONTROLLED STUDY; EPICARDIUM; EXTRASYSTOLE; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCN5A HEART; WILD TYPE;

ACTION POTENTIALS; ANIMALS; BRUGADA SYNDROME; CARDIAC PACING, ARTIFICIAL; ELECTROPHYSIOLOGY; HEART; MICE; MICE, MUTANT STRAINS; ORGAN CULTURE TECHNIQUES; SODIUM CHANNELS;

EID: 77956330945     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2010.02138.x     Document Type: Article

References (61)

1. Abello, M., Merino, J.L., Peinado, R. Gnoatto, M. 2006. Negative flecainide test in Brugada syndrome patients with previous positive response. Europace 8, 899 900.
2. Alings, M. Wilde, A. 1999. "Brugada" syndrome: clinical data and suggested pathophysiological mechanism. Circulation 99, 666 673.
3. Anno, T. Hondeghem, L.M. 1990. Interactions of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery. Circ Res 66, 789 803.
4. Antzelevitch, C., Brugada, P., Brugada, J. Brugada, R. 2005. Brugada syndrome: from cell to bedside. Curr Probl Cardiol 30, 9 54.
5. Armoundas, A.A., Osaka, M., Mela, T., Rosenbaum, D.S., Ruskin, J.N., Garan, H. Cohen, R. 1998. T-wave alternans and dispersion of the QT interval as risk stratification markers in patients susceptible to sustained ventricular arrhythmias. Am J Cardiol 82, 1127 1129.
6. Babij, P., Askew, G.R., Nieuwenhuijsen, B., Su, C.M., Bridal, T.R., Jow, B., Argentieri, T.M., Kulik, J., DeGennaro, L.J., Spinelli, W. Colatsky, T.J. 1998. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice. Circ Res 83, 668 678.
7. Balasubramaniam, R., Grace, A.A., Saumarez, R.C., Vandenberg, J.I. Huang, C.L.H. 2003. Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1. J Physiol 552, 535 546.
8. Belhassen, B., Glick, A. Viski, S. 2004. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 110, 1731 1737.
9. Benson, D.W., Wang, D.W., Dyment, M., Knilans, T.K., Fish, F.A., Strieper, M.J., Rhodes, T.H. George, A.L., Jr. 2003. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 112, 1019 1028.
10. Boyett, M.R., Honjo, H., Yamamoto, M., Niwa, R. Kodama, I. 1998. Regional differences in the effects of 4-aminopyridine within the sinoatrial node. Am J Physiol 44, H1158 H1168.
11. + currents in rat atrial myocytes. J Gen Physiol 100, 1041 1067.
12. Brugada, P. Brugada, J. 1992. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 20, 1391 1396.
13. Brugada, R., Brugada, J., Antzelevitch, C., Kirsch, G.E., Potenza, D., Towbin, J.A. Brugada, P. 2000. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 101, 510 515.
14. + currents in adult mouse ventricles. J Physiol 559, 103 120.
15. Calloe, K., Cordeiro, J.M., Di Diego, J.M., Hansen, R.S., Grunnet, M., Olesen, S.P. Antzelevitch, C. 2009. A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome. Cardiovasc Res 81, 686 694.
16. Danik, S., Cabo, C., Chiello, C., Kang, S., Wit, A.L. Coromilas, J. 2002. Correlation of repolarization of ventricular monophasic action potential with ECG in the murine heart. Am J Physiol Heart Circ Physiol 283, 372 381.
17. Domínguez, J.N., de la Rosa, A., Navarro, F., Franco, D. Aránega, A.E. 2008. Tissue distribution and subcellular localization of the cardiac sodium channel during mouse heart development. Cardiovasc Res 78, 45 52.
18. + channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome. Circ Res 83, 95 102.
19. Franz, M.R. 1999. Current status of monophasic action potential recording: theories, measurements and interpretations. Cardiovasc Res 41, 25 40.
20. Gaborit, N., Le Bouter, S., Szuts, V., Varro, A., Escande, D., Nattel, S. Demolombe, S. 2007. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol 582, 675 693.
21. Garrey, W. 1914. The nature of fibrillary contraction of the heart: its relation to tissue mass and form. Am J Physiol 33, 397 414.
22. Gehi, A.K., Stein, R.H., Metz, L.D. Gomes, J.A. 2005. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46, 75 82.
23. Gold, M.R., Bloomfield, D., Anderson, K.P., El-Sherif, N.E., Wilber, D.J., Groh, W.J., Estes, N.A.M., Kaufman, E.S., Greenberg, M.L. Rosenbaum, D.S. 2000. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 36, 2247 2253.
24. + current diversity in mouse ventricular myocytes. J Physiol 521, 587 599.
25. Gussak, I., Antzelevitch, C., Bjerregaard, P., Towbin, J.A. Chaitman, B.R. 1999. The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 33, 5 15.
26. Head, C.E., Balasubramaniam, R., Thomas, G., Goddard, C., Lei, M., Colledge, W.H., Grace, A.A. Huang, C.L.H. 2005. Paced electrogram fractionation analysis of arrhythmogenic tendency in DeltaKPQ Scn5a mice. J Cardiovasc Electrophysiol 16, 1329 1340.
27. Hennersdorf, M.G., Niebch, V., Perings, C. Strauer, B.E. 2001. T wave alternans and ventricular arrhythmias in arterial hypertension. Hypertension 37, 199 203.
28. Jaccard, J. Wan, C.K. 1996. LISREL Approaches to Interaction Effects in Multiple Regression. Sage Publications, Thousand Oaks, CA.
29. Katoria, K., Homma, M., Kugac, K., Yamaguchic, I., Sugibayashia, K. Kohda, Y. 2003. Liquid chromatographic determination of unbound flecainide in therapeutic drug monitoring. J Pharm Biomed Anal 32, 375 380.
30. Killeen, M.J., Thomas, G., Sabir, I.N., Grace, A.A. Huang, C.L.-H. 2008. Mouse models of human arrhythmia syndromes. Acta Physiol 192, 455 469.
31. Knollmann, B.C., Katchman, A.N. Franz, M.R. 2001. Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness. J Cardiovasc Electrophysiol 12, 1286 1294.
32. Krishnan, S.C. Antzelevitch, C. 1993. Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry? Circulation 87, 562 572.
33. Kurita, T., Shimizu, W., Inagaki, M., Suyama, K., Taguchi, A., Satomi, K., Aihara, N., Kamakura, S., Kobayashi, J. Kosakai, Y. 2002. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 40, 330 334.
34. Lei, M., Goddard, C., Liu, J., Leoni, A.L., Royer, A., Fung, S.S., Xiao, G., Ma, A., Zhang, H., Charpentier, F., Vandenberg, J.I., Colledge, W.H., Grace, A.A. Huang, C.L.-H. 2005. Sinus node dysfunction following targeted disruption of the murine cardiac sodium channel gene Scn5a. J Physiol 567, 387 400.
35. Lewis, T. 1911. Notes upon alternation of the heart. QJM 4, 141 144.
36. Liu, D.W., Gintant, G.A. Antzelevitch, C. 1993. Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res 72, 671 687.
37. Meregalli, P.G., Ruijter, J.M., Hofman, N., Bezzina, C.R., Wilde, A.A. Tan, H.L. 2006. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 17, 857 864.
38. Nearing, B.D., Huang, A.H. Verrier, R.L. 1991. Dynamic tracking of cardiac vulnerability by complex demodulation of the T wave. Science 252, 437 440.
39. Nerbonne, J.M. 2004. Studying cardiac arrhythmias in the mouse - a reasonable model for probing mechanisms? Trends Cardiovasc Med 14, 83 93.
40. + channel function in mice: what have we learned, and where do we go from here? Circ Res 89, 944 956.
41. Noble, D. 1984. The Initiation of the Heartbeat, 3rd edn. Clarendon Press, Oxford.
42. Papadatos, G.A., Wallerstein, P.M., Head, C.E., Ratcliffe, R., Brady, P.A., Benndorf, K., Saumarez, R.C., Trezise, A.E., Huang, C.L.H., Vandenberg, J.I., Colledge, W.H. Grace, A.A. 2002. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci USA 99, 6210 6215.
43. Priori, S.G., Napolitano, C., Schwartz, P.J., Bloise, R., Crotti, L. Ronchetti, E. 2000. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation 102, 945 947.
44. Ramos, E. O'Leary, M.E. 2004. State-dependent trapping of flecainide in the cardiac sodium channel. J Physiol 560, 37 49.
45. Remme, C.A., Verkerk, A.O., Hoogaars, W.M., Aanhaanen, W.T., Scicluna, B.P., Annink, C., van den Hoff, M.J., Wilde, A.A., van Veen, T.A., Veldkamp, M.W., de Bakker, J.M., Christoffels, V.M. Bezzina, C.R. 2009. The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol 104, 511 522.
46. Rosati, B., Grau, F., Rodriguez, S., Li, H., Nerbonne, J.M. McKinnon, D. 2003. Concordant expression of KChIP2 mRNA, protein and transient outward current throughout the canine ventricle. J Physiol 548, 815 822.
47. Rosenbaum, D.S., Jackson, L.E., Smith, J.M., Garan, H., Ruskin, J.N. Cohen, R.J. 1994. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330, 235 241.
48. Sabir, I.N., Li, L.M., Jones, V.J., Goddard, C.A., Grace, A.A. Huang, C.L.H. 2007. Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome. Eur J Physiol 455, 637 651.
49. Sabir, I.N., Killeen, M.J., Grace, A.A. Huang, C.L.-H. 2008. Ventricular arrhythmogenesis: insights from murine models. Prog Biophys Mol Biol 98, 208 218.
50. Sinha, M.K., Dasgupta, D. Lyons, J.P. 2004. Flecainide challenge test for the diagnosis of Brugada syndrome. Postgrad Med J 80, 723.
51. Starmer, C.F., Lastra, A.A., Nesterenko, V.V. Grant, A.O. 1991. Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments. Circulation 84, 1364 1377.
52. +/- murine hearts modelling the Brugada syndrome. J Physiol 581, 255 275.
53. Teutsch, C., Kondo, R.P., Dederko, D.A., Chrast, J., Chien, K.R. Giles, W.R. 2007. Spatial distributions of Kv4 channels and KChip2 isoforms in the murine heart based on laser capture microdissection. Cardiovasc Res 73, 739 749.
54. Traube, L. 1872. Ein fall von pulsus bigeminus nebst bemerkungen tiber die lebershwellungen bei klappenfehlern und uber acute leberatrophic. Ber Klin Wschr 9, 185.
55. Vaidya, D., Morley, G.E., Samie, F.H. Jalife, J. 1999. Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis. Circ Res 85, 174 181.
56. Viswanathan, P.C., Bezzina, C.R., George, A.L., Jr., Roden, D.M., Wilde, A.A. Balser, J.R. 2001. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. Circulation 104, 1200 1205.
57. Watanabe, M.A., Fenton, F.H., Evans, S.J., Hastings, H.M. Karma, A. 2001. Mechanisms for discordant alternans. J Cardiovasc Electrophysiol 12, 196 206.
58. Wiggers, C.J. 1930. Studies of ventricular fibrillation caused by electric shock, II: cinematographic and electrocardiographic observation of the natural process in the dog's heart. Its inhibition by potassium and the revival of coordinated beats by calcium. Am Heart J 5, 351 365.
59. Yan, G.X. Antzelevitch, C. 1996. Cellular basis for the electrocardiographic J wave. Circulation 93, 372 379.
60. Yan, G.X. Antzelevitch, C. 1999. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 100, 1660 1666.
61. + channel isoforms at the atrioventricular junction and atrioventricular node in the rat. Circulation 114, 1360 1371.